Letter to the Editor
Immune-mediated necrotising myopathy after treatment with adalimumab in a patient with HLA-B27 ankylosing spondylitis
Miopatía necrotizante inmunomediada tras tratamiento con adalimumab en paciente con espondilitis anquilosante HLA-B27
Read
4308
Timeswas read the article
606
Total PDF
3702
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 47 | 3 | 50 |
| 2025 11 | 241 | 57 | 298 |
| 2025 10 | 208 | 30 | 238 |
| 2025 9 | 133 | 32 | 165 |
| 2025 8 | 112 | 22 | 134 |
| 2025 7 | 122 | 12 | 134 |
| 2025 6 | 90 | 9 | 99 |
| 2025 5 | 104 | 11 | 115 |
| 2025 4 | 102 | 6 | 108 |
| 2025 3 | 86 | 13 | 99 |
| 2025 2 | 85 | 9 | 94 |
| 2025 1 | 85 | 9 | 94 |
| 2024 12 | 53 | 5 | 58 |
| 2024 11 | 55 | 7 | 62 |
| 2024 10 | 54 | 5 | 59 |
| 2024 9 | 52 | 16 | 68 |
| 2024 8 | 71 | 21 | 92 |
| 2024 7 | 54 | 14 | 68 |
| 2024 6 | 61 | 12 | 73 |
| 2024 5 | 28 | 7 | 35 |
| 2024 4 | 41 | 8 | 49 |
| 2024 3 | 63 | 6 | 69 |
| 2024 2 | 74 | 2 | 76 |
| 2024 1 | 90 | 10 | 100 |
| 2023 12 | 69 | 16 | 85 |
| 2023 11 | 90 | 7 | 97 |
| 2023 10 | 71 | 5 | 76 |
| 2023 9 | 52 | 6 | 58 |
| 2023 8 | 49 | 7 | 56 |
| 2023 7 | 41 | 7 | 48 |
| 2023 6 | 52 | 8 | 60 |
| 2023 5 | 111 | 4 | 115 |
| 2023 4 | 69 | 3 | 72 |
| 2023 3 | 45 | 11 | 56 |
| 2023 2 | 33 | 8 | 41 |
| 2023 1 | 46 | 14 | 60 |
| 2022 12 | 43 | 8 | 51 |
| 2022 11 | 72 | 10 | 82 |
| 2022 10 | 78 | 17 | 95 |
| 2022 9 | 40 | 12 | 52 |
| 2022 8 | 90 | 14 | 104 |
| 2022 7 | 68 | 7 | 75 |
| 2022 6 | 55 | 10 | 65 |
| 2022 5 | 48 | 4 | 52 |
| 2022 4 | 46 | 12 | 58 |
| 2022 3 | 58 | 12 | 70 |
| 2022 2 | 60 | 8 | 68 |
| 2022 1 | 71 | 10 | 81 |
| 2021 12 | 53 | 11 | 64 |
| 2021 11 | 47 | 19 | 66 |
| 2021 10 | 34 | 13 | 47 |
| 2021 9 | 0 | 6 | 6 |
| 2021 8 | 0 | 5 | 5 |
| 2021 7 | 0 | 6 | 6 |
Show all
